Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy

Lung transplantation remains as a primary treatment for end-stage lung diseases. Although remarkable improvement has been achieved due to the immunosuppressive protocols, long-term survival for lung transplant recipients (LTR) is still limited. In the last few decades, an increasing interest has gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Iglesias-Escudero, María, Segundo, David San, Merino-Fernandez, David, Mora-Cuesta, Victor M., Lamadrid, Patricia, Alonso-Peña, Marta, Raso, Sandra, Iturbe, David, Fernandez-Rozas, Sonia, Cifrian, Jose, López-Hoyos, Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848105/
https://www.ncbi.nlm.nih.gov/pubmed/35185863
http://dx.doi.org/10.3389/fimmu.2021.788851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848105/
https://www.ncbi.nlm.nih.gov/pubmed/35185863
http://dx.doi.org/10.3389/fimmu.2021.788851

Ejemplares similares